Christopher W. Krueger is CHIEF BUSINESS OFFICER at Ventyx Biosciences, Inc. (VTYX). They have made 14 open-market trades across 2 companies since 2009, most recently 2024-04-02.
CIK 0001394208
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VTYX | SELL | 2024-04-02 | 2024-04-03 | $5.40 | $9K | -8.1% | -4.5% | -57.9% |
| VTYX | SELL | 2023-12-20 | 2023-12-21 | $2.12 | $11K | +11.6% | -9.8% | +233.3% |
| VTYX | SELL | 2023-10-03 | 2023-10-04 | $29.96 | $869K | -33.9% | -44.8% | -91.2% |
| VTYX | SELL | 2023-09-05 | 2023-09-07 | $32.61 | $977K | +12.7% | -10.0% | -93.5% |
| VTYX | SELL | 2023-08-03 | 2023-08-04 | $35.59 | $1.1M | -15.2% | -8.6% | -58.9% |
| VTYX | SELL | 2023-07-03 | 2023-07-05 | $39.43 | $1.1M | -4.3% | -4.7% | -18.7% |
| VTYX | SELL | 2023-06-05 | 2023-06-06 | $34.36 | $1.0M | -8.4% | +6.2% | -7.7% |
| VTYX | SELL | 2023-05-03 | 2023-05-04 | $38.65 | $1.2M | -12.0% | -12.1% | -5.9% |
| VTYX | SELL | 2023-04-03 | 2023-05-04 | $32.88 | $986K | -12.0% | -12.1% | -5.9% |
| VTYX | SELL | 2022-12-22 | 2022-12-23 | $31.61 | $231K | +2.8% | +11.4% | +16.6% |
| VTYX | SELL | 2022-12-13 | 2022-12-15 | $34.46 | $1.0M | -5.7% | +3.7% | +14.6% |
| VTYX | SELL | 2022-12-02 | 2022-12-06 | $29.01 | $1.5M | +20.0% | +12.6% | +61.2% |
| VTYX | SELL | 2022-04-03 | 2023-04-05 | $32.88 | $986K | +28.6% | +38.7% | +32.7% |
| RDEA | SELL · 10b5-1 | 2010-07-23 | 2010-07-26 | $18.54 | $56K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2010-06-23 | 2010-06-24 | $21.93 | $66K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2010-05-24 | 2010-05-26 | $22.97 | $69K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2010-05-17 | 2010-05-18 | $23.19 | $27K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2010-04-23 | 2010-04-26 | $26.24 | $79K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2010-03-23 | 2010-03-24 | $18.45 | $166K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2009-12-23 | 2009-12-24 | $15.11 | $91K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2009-10-23 | 2009-10-26 | $15.25 | $46K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2009-09-23 | 2009-09-24 | $18.89 | $57K | N/A | N/A | N/A |
| RDEA | SELL · 10b5-1 | 2009-08-24 | 2009-08-25 | $19.00 | $96K | N/A | N/A | N/A |
| RDEA | SELL | 2009-05-19 | 2009-05-21 | $15.02 | $413K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.